Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Kwon, C.-H., Zhu, X., Zhang, J., Knoop, L. L., Tharp, R., Smeyne, R. J., Eberhart, C. G., Burger, P. C., & Baker, S. J. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nature Genetics, 29(4), 404–411.

Authors 9
  1. Chang-Hyuk Kwon (first)
  2. Xiaoyan Zhu (additional)
  3. Junyuan Zhang (additional)
  4. Lori L. Knoop (additional)
  5. Ruby Tharp (additional)
  6. Richard J. Smeyne (additional)
  7. Charles G. Eberhart (additional)
  8. Peter C. Burger (additional)
  9. Suzanne J. Baker (additional)
References 50 Referenced 382
  1. Maehama, T. & Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998). (10.1074/jbc.273.22.13375) / J. Biol. Chem. by T Maehama (1998)
  2. Leevers, S.J., Vanhaesebroeck, B. & Waterfield, M.D. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11, 219–225 (1999). (10.1016/S0955-0674(99)80029-5) / Curr. Opin. Cell Biol. by SJ Leevers (1999)
  3. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997). (10.1126/science.275.5308.1943) / Science by J Li (1997)
  4. Steck, P.A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356–362 (1997). (10.1038/ng0497-356) / Nature Genet. by PA Steck (1997)
  5. Bonneau, D. & Longy, M. Mutations of the human PTEN gene. Hum. Mutat. 16, 109–122 (2000). (10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0) / Hum. Mutat. by D Bonneau (2000)
  6. Dahia, P.L. et al. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum. Mol. Genet. 8, 185–193 (1999). (10.1093/hmg/8.2.185) / Hum. Mol. Genet. by PL Dahia (1999)
  7. Wu, X., Senechal, K., Neshat, M.S., Whang, Y.E. & Sawyers, C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl Acad. Sci. USA 95, 15587–15591 (1998). (10.1073/pnas.95.26.15587) / Proc. Natl Acad. Sci. USA by X Wu (1998)
  8. Marsh, D.J. et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 8, 1461–1472 (1999). (10.1093/hmg/8.8.1461) / Hum. Mol. Genet. by DJ Marsh (1999)
  9. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P.P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998). (10.1038/1235) / Nature Genet. by A Di Cristofano (1998)
  10. Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169–1178 (1998). (10.1016/S0960-9822(07)00488-5) / Curr. Biol. by A Suzuki (1998)
  11. Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563–1568 (1999). (10.1073/pnas.96.4.1563) / Proc. Natl Acad. Sci. USA by K Podsypanina (1999)
  12. Stambolic, V. et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in Pten+/− mice. Cancer Res. 60, 3605–3611 (2000). / Cancer Res. by V Stambolic (2000)
  13. Di Cristofano, A. et al. Impaired Fas response and autoimmunity in Pten+/− mice. Science 285, 2122–2125 (1999). (10.1126/science.285.5436.2122) / Science by A Di Cristofano (1999)
  14. Suzuki, A. et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523–534 (2001). (10.1016/S1074-7613(01)00134-0) / Immunity by A Suzuki (2001)
  15. Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P.P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genet. 27, 222–224 (2001). (10.1038/84879) / Nature Genet. by A Cristofano (2001)
  16. Li, Y. et al. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol. Biol. 2, 2 (2001). (10.1186/1471-2199-2-2) / BMC Mol. Biol. by Y Li (2001)
  17. Toggas, S.M. et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188–193 (1994). (10.1038/367188a0) / Nature by SM Toggas (1994)
  18. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genet. 21, 70–71 (1999). (10.1038/5007) / Nature Genet. by P Soriano (1999)
  19. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994–1004 (2000). (10.1101/gad.14.8.994) / Genes Dev. by S Marino (2000)
  20. Goldowitz, D., Hamre, K.M., Przyborski, S.A. & Ackerman, S.L. Granule cells and cerebellar boundaries: analysis of Unc5h3 mutant chimeras. J. Neurosci. 20, 4129–4137 (2000). (10.1523/JNEUROSCI.20-11-04129.2000) / J. Neurosci. by D Goldowitz (2000)
  21. Zhu, Y. et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15, 859–876 (2001). (10.1101/gad.862101) / Genes Dev. by Y Zhu (2001)
  22. Mucke, L., Oldstone, M.B., Morris, J.C. & Nerenberg, M.I. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 3, 465–474 (1991). / New Biol. by L Mucke (1991)
  23. Kuhar, S.G. et al. Changing patterns of gene expression define four stages of cerebellar granule neuron differentiation. Development 117, 97–104 (1993). (10.1242/dev.117.1.97) / Development by SG Kuhar (1993)
  24. Cantley, L.C. & Neel, B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci.USA 96, 4240–4245 (1999). (10.1073/pnas.96.8.4240) / Proc. Natl Acad. Sci.USA by LC Cantley (1999)
  25. Bruni, P. et al. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene 19, 3146–3155 (2000). (10.1038/sj.onc.1203633) / Oncogene by P Bruni (2000)
  26. Sun, H. et al. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl Acad. Sci. USA 96, 6199–6204 (1999). (10.1073/pnas.96.11.6199) / Proc. Natl Acad. Sci. USA by H Sun (1999)
  27. Nakamura, N. et al. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20, 8969–8982 (2000). (10.1128/MCB.20.23.8969-8982.2000) / Mol. Cell. Biol. by N Nakamura (2000)
  28. Mamillapalli, R. et al. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr. Biol. 11, 263–267 (2001). (10.1016/S0960-9822(01)00065-3) / Curr. Biol. by R Mamillapalli (2001)
  29. Rainov, N.G., Holzhausen, H.J. & Burkert, W. Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease). Clin. Neurol. Neurosurg. 97, 175–180 (1995). (10.1016/0303-8467(95)00017-E) / Clin. Neurol. Neurosurg. by NG Rainov (1995)
  30. Tuli, S., Provias, J.P. & Bernstein, M. Lhermitte-Duclos disease: literature review and novel treatment strategy. Can. J. Neurol. Sci. 24, 155–160 (1997). (10.1017/S031716710002151X) / Can. J. Neurol. Sci. by S Tuli (1997)
  31. Marcus, C.D. et al. Lhermitte-Duclos disease associated with syringomyelia. Neuroradiology 38, 529–531 (1996). (10.1007/BF00626089) / Neuroradiology by CD Marcus (1996)
  32. Robinson, S. & Cohen, A.R. Cowden disease and Lhermitte-Duclos disease: characterization of a new phakomatosis. Neurosurgery 46, 371–383 (2000). (10.1097/00006123-200002000-00021) / Neurosurgery by S Robinson (2000)
  33. Iida, S. et al. A heterozygous frameshift mutation of the PTEN/MMAC1 gene in a patient with Lhermitte-Duclos disease—only the mutated allele was expressed in the cerebellar tumor. Int. J. Mol. Med. 1, 925–929 (1998). / Int. J. Mol. Med. by S Iida (1998)
  34. Vinchon, M. et al. Association of Lhermitte-Duclos and Cowden disease: report of a new case and review of the literature. J. Neurol. Neurosurg. Psychiatry 57, 699–704 (1994). (10.1136/jnnp.57.6.699) / J. Neurol. Neurosurg. Psychiatry by M Vinchon (1994)
  35. Li, J. et al. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58, 5667–5672 (1998). / Cancer Res. by J Li (1998)
  36. Davies, M.A. et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58, 5285–5290 (1998). / Cancer Res. by MA Davies (1998)
  37. Furnari, F.B., Huang, H.J. & Cavenee, W.K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58, 5002–5008 (1998). / Cancer Res. by FB Furnari (1998)
  38. Cheney, I.W., Neuteboom, S.T., Vaillancourt, M.T., Ramachandra, M. & Bookstein, R. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res. 59, 2318–2323 (1999). / Cancer Res. by IW Cheney (1999)
  39. Li, D.M. & Sun, H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl Acad. Sci. USA 95, 15406–15411 (1998). (10.1073/pnas.95.26.15406) / Proc. Natl Acad. Sci. USA by DM Li (1998)
  40. Zhu, X., Kwon, C.H., Schlosshauer, P.W., Ellenson, L.H. & Baker, S.J. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res. 61, 4569–4575 (2001). / Cancer Res. by X Zhu (2001)
  41. Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927 (1999). (10.1101/gad.13.22.2905) / Genes Dev. by SR Datta (1999)
  42. Dudek, H. et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661–665 (1997). (10.1126/science.275.5300.661) / Science by H Dudek (1997)
  43. Gao, X., Neufeld, T.P. & Pan, D. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways. Dev. Biol. 221, 404–418 (2000). (10.1006/dbio.2000.9680) / Dev. Biol. by X Gao (2000)
  44. Goberdhan, D.C., Paricio, N., Goodman, E.C., Mlodzik, M. & Wilson, C. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13, 3244–3258 (1999). (10.1101/gad.13.24.3244) / Genes Dev. by DC Goberdhan (1999)
  45. Huang, H. et al. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126, 5365–5372 (1999). (10.1242/dev.126.23.5365) / Development by H Huang (1999)
  46. Stocker, H. & Hafen, E. Genetic control of cell size. Curr. Opin. Genet. Dev. 10, 529–535 (2000). (10.1016/S0959-437X(00)00123-4) / Curr. Opin. Genet. Dev. by H Stocker (2000)
  47. Shioi, T. et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19, 2537–2548 (2000). (10.1093/emboj/19.11.2537) / EMBO J. by T Shioi (2000)
  48. Tuttle, R.L. et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nature Med. 7, 1133–1137 (2001). (10.1038/nm1001-1133) / Nature Med. by RL Tuttle (2001)
  49. Gu, H., Zou, Y.R. & Rajewsky, K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73, 1155–1164 (1993). (10.1016/0092-8674(93)90644-6) / Cell by H Gu (1993)
  50. Miyazawa, K. et al. A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation. J. Neurosci. 20, 5756–5763 (2000). (10.1523/JNEUROSCI.20-15-05756.2000) / J. Neurosci. by K Miyazawa (2000)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:34 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:16 p.m.)
Indexed 1 month, 2 weeks ago (July 20, 2025, 12:06 a.m.)
Issued 23 years, 9 months ago (Nov. 19, 2001)
Published 23 years, 9 months ago (Nov. 19, 2001)
Published Online 23 years, 9 months ago (Nov. 19, 2001)
Published Print 23 years, 9 months ago (Dec. 1, 2001)
Funders 0

None

@article{Kwon_2001, title={Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease}, volume={29}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng781}, DOI={10.1038/ng781}, number={4}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Kwon, Chang-Hyuk and Zhu, Xiaoyan and Zhang, Junyuan and Knoop, Lori L. and Tharp, Ruby and Smeyne, Richard J. and Eberhart, Charles G. and Burger, Peter C. and Baker, Suzanne J.}, year={2001}, month=nov, pages={404–411} }